Voyager Therapeutics Inc (VYGR)

May 22, 2026

Voyager Therapeutics Inc. (VYGR) Q1 2026 Earnings: Narrowed Loss Meets Optimism in Gene Therapy PipelineEPS Consistency Score - Newser

May 22, 2026

May 22, 2026

Voyager Therapeutics Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ResponseNet Income Trends - Newser

May 22, 2026

May 22, 2026

Voyager Therapeutics (VYGR) Shares Rebound 4.76% as Biotech Sector Shows StrengthCrowd Risk Alerts - Newser

May 22, 2026

May 20, 2026

- Insider Monkey

May 20, 2026

May 20, 2026

What Voyager Therapeutics Inc (VYGR) Has Gained on Its Therapy Programs - Insider Monkey

May 20, 2026

May 18, 2026

Voyager Therapeutics (VYGR) accounting officer reports initial share and option holdings - Stock Titan

May 18, 2026

May 17, 2026

The one question every Voyager Therapeutics VYGR investor should ask Bullish Sentiment 20260510High Attention Stocks - Newser

May 17, 2026

May 15, 2026

VYGR (NASDAQ: VYGR) affiliate files Form 144 to sell 25,000 shares - Stock Titan

May 15, 2026

May 15, 2026

EcoR1 and Oleg Nodelman report 0 shares in Voyager (NASDAQ: VYGR) amendment - Stock Titan

May 15, 2026

May 15, 2026

Armistice Capital (VYGR) reports 3.5M shares, 5.87% stake in Voyager - Stock Titan

May 15, 2026

May 15, 2026

Voyager Therapeutics (NASDAQ: VYGR) affiliate files to sell 9,406 shares - Stock Titan

May 15, 2026

May 15, 2026

Wedbush Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $8 - Moomoo

May 15, 2026

May 14, 2026

TradingKey - TradingKey

May 14, 2026

May 14, 2026

VYGR Technical Analysis | Trend, Signals & Chart Patterns | VOYAGER THERAPEUTICS INC (NASDAQ:VYGR) - ChartMill

May 14, 2026

May 13, 2026

Voyager presents preclinical data for Alzheimer’s gene therapy By Investing.com - Investing.com India

May 13, 2026

May 13, 2026

Voyager Therapeutics (VYGR) Reports Positive Findings for Alzhei - GuruFocus

May 13, 2026

May 13, 2026

VYGR Secures Mission Management Contract for ISS Research - GuruFocus

May 13, 2026

May 13, 2026

Voyager presents preclinical data for Alzheimer’s gene therapy - Investing.com UK

May 13, 2026

May 13, 2026

Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026 - The Manila Times

May 13, 2026

May 13, 2026

Voyager Therapeutics Advances VY1706 Gene Therapy for Alzheimer's Disease with IND Application on Track for Q2 2026 - Quiver Quantitative

May 13, 2026

May 13, 2026

Voyager Therapeutics Presents Three-Month GLP Toxicology Data For VY1706 And Provides Updates On Gene Therapy Pipeline - marketscreener.com

May 13, 2026

May 11, 2026

CCORF Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $12 - Moomoo

May 11, 2026

May 10, 2026

The one question every Voyager Therapeutics (VYGR) investor should ask (Bullish Sentiment) 2026-05-10Social Momentum Signals - newser.com

May 10, 2026

May 09, 2026

Voyager Therapeutics Announces CFO Resignation and Finance Leadership Changes - TipRanks

May 09, 2026

May 09, 2026

Voyager Therapeutics (NASDAQ:VYGR) Rating Lowered to Sell at Wall Street Zen - MarketBeat

May 09, 2026

May 09, 2026

Voyager Therapeutics Warns of Broad Risk Exposure and Uncertain Outlook in Latest SEC Filings - TipRanks

May 09, 2026

May 08, 2026

Voyager Therapeutics stock (US92916U1025): Q1 2026 results and pipeline updates drive sentiment - AD HOC NEWS

May 08, 2026

May 08, 2026

Voyager Therapeutics (VYGR) reports Q1 loss, misses revenue estimates - MSN

May 08, 2026

May 08, 2026

Voyager Therapeutics: Q1 Earnings Snapshot - theheraldreview.com

May 08, 2026

May 07, 2026

Voyager Therapeutics (VYGR) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance

May 07, 2026

May 07, 2026

Alzheimer’s gene therapy moves toward human testing as cash lasts into 2028 - Stock Titan

May 07, 2026

May 07, 2026

Voyager Therapeutics (Nasdaq: VYGR) posts Q1 2026 loss and advances tau drugs - Stock Titan

May 07, 2026

May 07, 2026

Voyager Therapeutics (Nasdaq: VYGR) trims Q1 2026 loss, holds $171.7M cash - Stock Titan

May 07, 2026

May 07, 2026

Voyager Reports First Quarter 2026 Financial and Operating Results - marketscreener.com

May 07, 2026

May 06, 2026

VOYAGER THERAPEUTICS, INC. (VYGR) - MSN

May 06, 2026

May 05, 2026

Voyager Therapeutics CFO resigns; Robin Swartz takes financial charge - MSN

May 05, 2026

May 05, 2026

The key driver behind Voyager Therapeutics (VYGR) revenue growth | Q4 2025: Better Than ExpectedDividend Report - Newser

May 05, 2026

May 04, 2026

MSN Money - MSN

May 04, 2026

May 02, 2026

Voyager Therapeutics Inc (VYGR) - MSN

May 02, 2026

May 01, 2026

Voyager Therapeutics Inc expected to post a loss of 53 cents a shareEarnings Preview - TradingView

May 01, 2026

May 01, 2026

Voyager Therapeutics (VYGR) Stock: Support Breakdown Risk | Q4 2025: EPS Beats ForecastsEBITDA Estimate Trend - Newser

May 01, 2026

Apr 30, 2026

H.C. Wainwright Reaffirms Their Buy Rating on Voyager Therapeutics (VYGR) - The Globe and Mail

Apr 30, 2026

Apr 29, 2026

H.C. Wainwright Maintains Voyager Therapeutics(VYGR.US) With Buy Rating, Maintains Target Price $25 - Moomoo

Apr 29, 2026